- Posts by Kelsey J. McElveen
OfficerAs a member of the firm’s Intellectual Property Litigation group, Kelsey focuses her practice on patent litigation under the Hatch-Waxman Act. After nearly a decade of experience working on Abbreviated New Drug Application ...
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
- EventHealth Law Webinar – The Annual Regulatory Update 2024
- Event2025 Minnesota Legislative Session Outlook
- EventWhat Faculty, Scholars, Researchers, Students (and Their Institutions) Need to Know Before Starting the Employment Based Green Card Process
- Legal UpdateIt’s a Gas: Minnesota and Iowa Race to Regulate Newly Discovered Reserves of Helium and Hydrogen